Phromnoi Kanokkarn, Suttajit Maitree, Saenjum Chalermpong, Limtrakul Dejkriengkraikul Pornngarm
Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Antioxidants (Basel). 2021 Feb 17;10(2):307. doi: 10.3390/antiox10020307.
The aim of this study is to determine antioxidant and anti-inflammatory activities relating to the antiosteoporosis effects of various perilla seed meal (PSM) fractions. The remaining waste of perilla seed obtained from cold oil compression was extracted with 70% ethanol and sequentially fractionated according to solvent polarity with hexane, dichloromethane, ethyl acetate, and water. The results indicated that the seed-meal ethyl acetate fraction (SMEF) exhibited the highest antioxidant and anti-inflammatory activities, and rosmarinic acid (RA) content. The signaling pathways induced by the receptor activator of the nuclear factor kappa B (NF-κB) ligand (RANKL) that trigger reactive oxygen species (ROS) and several transcription factors, leading to the induction of osteoclastogenesis, were also investigated. The SMEF clearly showed attenuated RANKL-induced tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclasts and TRAP activity. A Western blot analysis showed that the SMEF significantly downregulated RANKL-induced NF-κB, AP-1 activation, and the nuclear factor of activated T-cell 1 (NFATc1) expression. SMEF also suppressed RANKL-induced osteoclast-specific marker gene-like MMP-9 using zymography. Furthermore, the SMEF showed inhibition of RANKL-induced ROS production in RAW 264.7 cells. The results suggest that the SMEF, which contained high quantities of RA, could be developed as a natural active pharmaceutical ingredient for osteoclastogenic protection and health promotion.
本研究旨在确定各种紫苏籽粕(PSM)组分与抗骨质疏松作用相关的抗氧化和抗炎活性。从冷榨油得到的紫苏籽剩余废料用70%乙醇提取,并根据溶剂极性依次用己烷、二氯甲烷、乙酸乙酯和水进行分级分离。结果表明,籽粕乙酸乙酯级分(SMEF)表现出最高的抗氧化和抗炎活性以及迷迭香酸(RA)含量。还研究了由核因子κB(NF-κB)配体(RANKL)受体激活剂诱导的触发活性氧(ROS)和几种转录因子的信号通路,这些信号通路会导致破骨细胞生成。SMEF明显显示出RANKL诱导的抗酒石酸酸性磷酸酶(TRAP)阳性多核破骨细胞和TRAP活性减弱。蛋白质印迹分析表明,SMEF显著下调RANKL诱导的NF-κB、AP-1激活以及活化T细胞核因子1(NFATc1)的表达。SMEF还通过酶谱法抑制RANKL诱导的破骨细胞特异性标记基因样MMP-9。此外,SMEF显示出对RAW 264.7细胞中RANKL诱导的ROS产生的抑制作用。结果表明,含有大量RA的SMEF可开发为用于破骨细胞生成保护和促进健康的天然活性药物成分。